Ethinyl Estradiol; Norethindrone

Drug Usage Statistics, United States, 2008 - 2018

Ethinyl Estradiol; Norethindrone Summary for 2018

Estimated number of prescriptions in the United States 13,509,602
Top drug rank #57 ( 4)
Average total drug cost $73.72 (USD)
Average out-of-pocket cost $7.97 (USD)

Number of Prescriptions Over Time (2008 - 2018)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2008 105  3
2009 112  7
2010 69  43
2011 66  3
2012 64  2
2013 59  5
Year Rank Change
2014 60  1
2015 61  1
2016 55  6
2017 53  2
2018 57  4

Drug Cost Over Time (2008 - 2018)

  • Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
  • Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Alyacen 1/35
  • Alyacen 7/7/7
  • Aranelle
  • Balziva-21
  • Balziva-28
  • Brevicon 21-day
  • Brevicon 28-day
  • Briellyn
  • Cyclafem 0.5/35
  • Cyclafem 1/35
  • Cyclafem 7/7/7
  • Cyonanz
  • Dasetta 1/35
  • Dasetta 7/7/7
  • Femcon FE
  • Gencept 10/11-21
  • Gencept 10/11-28
  • Gildagia
  • Kaitlib FE
  • Modicon 21
  • Modicon 28
  • N.E.E. 1/35 21
  • N.E.E. 1/35 28
  • Nexesta FE
  • Norcept-e 1/35 21
  • Norcept-e 1/35 28
  • Norethin 1/35e-21
  • Norethin 1/35e-28
  • Norethindrone And Ethinyl Estradiol
  • Norethindrone And Ethinyl Estradiol (10/11)
  • Norethindrone And Ethinyl Estradiol (7/14)
  • Norethindrone And Ethinyl Estradiol And Ferrous Fumarate
  • Norinyl 1+35 21-day
  • Norinyl 1+35 28-day
  • Nortrel 0.5/35-21
  • Nortrel 0.5/35-28
  • Nortrel 1/35-21
  • Nortrel 1/35-28
  • Nortrel 7/7/7
  • Nylia 1/35
  • Nylia 7/7/7
  • Ortho-novum 1/35-21
  • Ortho-novum 1/35-28
  • Ortho-novum 10/11-21
  • Ortho-novum 10/11-28
  • Ortho-novum 7/14-21
  • Ortho-novum 7/14-28
  • Ortho-novum 7/7/7-21
  • Ortho-novum 7/7/7-28
  • Ovcon-35
  • Ovcon-50
  • Philith
  • Pirmella 1/35
  • Pirmella 7/7/7
  • Tri-norinyl 21-day
  • Tri-norinyl 28-day
  • Vyfemla
  • Wera
  • Aurovela 1.5/30
  • Aurovela 1/20
  • Aurovela 24 FE
  • Aurovela FE 1.5/30
  • Aurovela FE 1/20
  • Blisovi 24 FE
  • Blisovi FE 1.5/30
  • Blisovi FE 1/20
  • Chabelina FE
  • Estrostep 21
  • Estrostep FE
  • Femhrt
  • Finzala
  • Fyavolv
  • Gildess 1.5/30
  • Gildess 1/20
  • Gildess 24 FE
  • Gildess FE 1.5/30
  • Gildess FE 1/20
  • Hailey 1.5/30
  • Hailey FE 1.5/30
  • Hailey FE 1/20
  • Junel 1.5/30
  • Junel 1/20
  • Junel FE 1.5/30
  • Junel FE 1/20
  • Larin 1.5/30
  • Larin 1/20
  • Larin 24 FE
  • Larin FE 1.5/30
  • Larin FE 1/20
  • Leribane
  • LO Loestrin FE
  • LO Minastrin FE
  • Loestrin 21 1.5/30
  • Loestrin 21 1/20
  • Loestrin 24 FE
  • Loestrin FE 1.5/30
  • Loestrin FE 1/20
  • Mibelas 24 FE
  • Microgestin 1.5/30
  • Microgestin 1/20
  • Microgestin FE 1.5/30
  • Microgestin FE 1/20
  • Minastrin 24 FE
  • Norethindrone Acetate And Ethinyl Estradiol
  • Norethindrone Acetate And Ethinyl Estradiol And Ethinyl Estradiol And Ferrous Fumarate
  • Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate
  • Norlestrin 21 1/50
  • Norlestrin 21 2.5/50
  • Norlestrin 28 1/50
  • Taytulla
  • Tri-legest 21
  • Tri-legest FE
Generic Drug Synonyms and Salts
  • Ethinyl Estradiol; Norethindrone Acetate
  • Norethindrone; Ethinyl Estradiol
  • Ethinyl Estradiol; Norethindrone

FDA Approval Information

Established Pharmacologic Class (EPC): N/A
Initial FDA approval date: Prior to January 1, 1982
First FDA applicant: Discn
First dosage form: Tablet (oral-21)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.1. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

 
©2021 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jan 18, 2021
Back to Top
Top